Philippe Merle
Université Claude Bernard Lyon 1
ORCID: 0000-0002-8230-394XAlso affiliated with Centre National de la Recherche Scientifique, Inserm, Lyon College, Center for the Study of Social Policy, Hôpital de la Croix-Rousse, Centre de Recherche en Neurosciences de Lyon, Communauté urbaine de Lyon, Centre Hospitalier Universitaire Amiens-Picardie, Hospices Civils de Lyon, Hôpital Lyon Sud, Centre de Recherche en Cancérologie de Lyon, HCL Technologies (India)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 3 papers. Top paper: “Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma”.
Shukui Qin, Masafumi Ikeda, Peter R. Galle, Michel Ducreux, Tae-You Kim +19 more
Bingyu Yan, Zhibin Cui, Jiazeng Sun, Sagar M. Utturkar, Adrien Foca +7 more
Guanhui Wu, Wen‐Hung Wang, Zhengtao Zhang, Philippe Merle, Lijian Hui +3 more